Comparison of the effectiveness of Intravenous Infusion of Ketamine and Dexmedetomidine on pain control

Comparison of the effectiveness of Intravenous Infusion of Ketamine and Dexmedetomidine on pain control after laparoscopic bariatric surgery

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230518058225N8

Enrollment

Registered

2025-01-06

Start date

2025-01-20

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain. Pain, not elsewhere classified

Interventions

Intervention 1: Intervention Group 1: In this group, intravenous infusion of dexmedetomidine 0.5 micrograms/kg (at a concentration of 100 micrograms/mL (manufacturer: Exir Pharmaceutical Company) will

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: The age range from 20 to 80 years Body mass index greater than 35 A person with normal health A person with mild systemic disease Bariatric surgery candidate

Exclusion criteria

Exclusion criteria: History of sensitivity to the study drugs Addiction to opioids and alcohol

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: At 30, 60 and 120 minutes after entering recovery. Method of measurement: Numerical pain rating scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactPejhman Aghaei

Iran University of Medical Sciences

Drpa1352@gmail.com+98 21 8214 1600

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026